Protective activity of hesperidin and lipoic acid against sodium arsenite acute toxicity in mice

被引:36
作者
das Neves, RNP
Carvalho, F
Carvalho, M
Fernandes, E
Soares, E
Bastos, MD
Pereira, MD
机构
[1] Univ Aveiro, Dept Biol, CICECO, P-3810193 Aveiro, Portugal
[2] Univ Porto, Fac Pharm, Dept Toxicol, REQUIMTE, P-4099033 Oporto, Portugal
关键词
hesperidin; lipoic acid; sodium arsenite; histopathology; mice; liver; kidney; testis;
D O I
10.1080/01926230490502566
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The objective of the present work was to evaluate the toxic effects of sodium arsenite, As(III), in mice and the protective effect of 2 antioxidants, hesperidin and lipoic acid, against the observed As(III)-induced toxicity. In each study, mice were assigned to 1 of 4 groups: control, antioxidant, antioxidant + arsenite, and arsenite. Animals were first injected with the vehicle or 25 mg antioxidant/kg BW. After 30 minutes they received an injection of 10 mg arsenite/kg BW or 0.9% NaCl. Two hours after the first injection, the liver, kidney, and testis were collected for histological evaluation. Liver samples were also taken for quantification of arsenic. In mice exposed only to As(III), various histopathological effects were observed in the liver, kidneys, and testes. In mice pretreated with either hesperidin or lipoic acid, a reduction of histopathologic effects on the liver and kidneys was observed. No protective effects were observed in the testes for either of the 2 studied antioxidants. In conclusion, hesperidin and lipoic acid provided protective effects against As(III)-induced acute toxicity in the liver and kidneys of mice. These compounds may potentially play an important role in the protection of populations chronically exposed to arsenic.
引用
收藏
页码:527 / 535
页数:9
相关论文
共 71 条
[1]   Enhanced arsenite-induced hepatic morphological and biochemical changes in phenobarbital-pretreated rats [J].
Albores, A ;
Cebrian, ME ;
GarciaVargas, GG ;
Connelly, JC ;
Price, SC ;
Hinton, RH ;
Bach, PH ;
Bridges, JW .
TOXICOLOGIC PATHOLOGY, 1996, 24 (02) :172-180
[2]   An original microhaemorheological approach to the pharmacological effects of Daflon 500 mg in severe chronic venous insufficiency [J].
Allegra, C ;
Bartolo, M ;
Carioti, B ;
Cassiani, D .
INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL, 1995, 15 :50-54
[3]  
Amiel M, 1998, ANN CARDIOL ANGEIOL, V47, P185
[4]   Inhibition of glucose production and stimulation of bile flow by R (+)-α-lipoic acid enantiomer in rat liver [J].
Anderwald, C ;
Koca, G ;
Fürnsinn, C ;
Waldhäusl, W ;
Roden, M .
LIVER, 2002, 22 (04) :356-362
[5]   Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic [J].
Aposhian, HV ;
Gurzau, ES ;
Le, XC ;
Gurzau, A ;
Healy, SM ;
Lu, XF ;
Ma, MS ;
Yip, L ;
Zakharyan, RA ;
Maiorino, RM ;
Dart, RC ;
Tircus, MG ;
Gonzalez-Ramirez, D ;
Morgan, DL ;
Avram, D ;
Aposhian, MM .
CHEMICAL RESEARCH IN TOXICOLOGY, 2000, 13 (08) :693-697
[6]   Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity [J].
Aposhian, HV .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :397-419
[7]  
APPLEGATE LA, 1991, CANCER RES, V51, P974
[8]  
*ATSDR, 2000, TOX PROF ARS UPD
[9]   Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite [J].
Barchowsky, A ;
Klei, LR ;
Dudek, EJ ;
Swartz, HM ;
James, PE .
FREE RADICAL BIOLOGY AND MEDICINE, 1999, 27 (11-12) :1405-1412
[10]   Acute arsenic poisoning:: clinical and histopathological features [J].
Bartolomé, B ;
Córdoba, S ;
Nieto, S ;
Fernández-Herrera, J ;
García-Díez, A .
BRITISH JOURNAL OF DERMATOLOGY, 1999, 141 (06) :1106-1109